- Home
- WABC vs IMTX Comparison
WABC vs IMTX Comparison
Compare WABC & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WABC | IMTX |
|---|---|---|
| Founded | 1972 | N/A |
| Country | United States | Germany |
| Employees | 627 | 407 |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | WABC | IMTX |
|---|---|---|
| Price | $54.52 | $11.73 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $54.00 | $19.00 |
| AVG Volume (30 Days) | 151.0K | ★ 327.6K |
| Earning Date | 04-16-2026 | 05-13-2026 |
| Dividend Yield | ★ 3.35% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.40 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $25.91 |
| P/E Ratio | $16.16 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $44.93 | $4.93 |
| 52 Week High | $56.22 | $12.41 |
Technical Indicators
Market Signals| Indicator | WABC | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 55.73 | 62.11 |
| Support Level | $46.73 | $8.97 |
| Resistance Level | $54.71 | $12.41 |
| Average True Range (ATR) | 0.86 | 0.51 |
| MACD | -0.10 | -0.00 |
| Stochastic Oscillator | 46.33 | 86.18 |
Price Performance
Historical ComparisonAbout WABC Westamerica Bancorporation
Westamerica Bancorp provides a full range of banking services to individual and commercial customers in Northern and Central California through its subsidiary bank. The Bank is a California-chartered commercial bank whose deposits are insured by the Federal Deposit Insurance Corporation (the FDIC) up to applicable limits. The principal communities served are located in Northern and Central California, from Mendocino, Lake and Nevada Counties in the north to Kern County in the south. The Company's strategic focus is on the banking needs of small businesses.
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.